PELLE', ELEONORA
PELLE', ELEONORA
1101MO Development of CAR T-cells for future treatment of NETs
2021-01-01 Mandriani, B.; Pelle', E.; Mannavola, F.; Ingravallo, G.; Cazzato, G.; Ramello, M. C.; Porta, C. G.; Strosberg, J. R.; Abate-Daga, D.; Cives, M.
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice
2020-01-01 Cives, M; Pelle', E; Rinzivillo, M; Prosperi, D; Tucci, M; Silvestris, F; Panzuto, F
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
2019-01-01 Cives, M.; Partelli, S.; Palmirotta, R.; Lovero, D.; Mandriani, B.; Quaresmini, D.; Pelle', E.; Andreasi, V.; Castelli, P.; Strosberg, J.; Zamboni, G.; Falconi, M.; Silvestris, F.
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
2020-01-01 Cives, Mauro; Pelle', Eleonora; Strosberg, Jonathan
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
2018-01-01 Palmirotta, Raffaele; Lovero, Domenica; Cafforio, Paola; Felici, Claudia; Mannavola, Francesco; Pellè, Eleonora; Quaresmini, Davide; Tucci, Marco Gaetano; Silvestris, Franco
PIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo
2017-01-01 Cafforio, Paola; Viggiano, Luigi; Mannavola, Francesco; Pellè, Eleonora; Caporusso, Concetta; Maiorano, Eugenio; Felici, Claudia; Silvestris, Francesco
The management of refractory carcinoid syndrome: challenges and opportunities ahead
2018-01-01 Cives, Mauro; Pelle', Eleonora; Silvestris, Franco
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.
2019-01-01 Cives, M; Pelle', E; Quaresmini, D; Mandriani, Barbara; Tucci, M; Silvestris, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1101MO Development of CAR T-cells for future treatment of NETs | 1-gen-2021 | Mandriani, B.; Pelle', E.; Mannavola, F.; Ingravallo, G.; Cazzato, G.; Ramello, M. C.; Porta, C. G.; Strosberg, J. R.; Abate-Daga, D.; Cives, M. | |
| Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice | 1-gen-2020 | Cives, M; Pelle', E; Rinzivillo, M; Prosperi, D; Tucci, M; Silvestris, F; Panzuto, F | |
| DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors | 1-gen-2019 | Cives, M.; Partelli, S.; Palmirotta, R.; Lovero, D.; Mandriani, B.; Quaresmini, D.; Pelle', E.; Andreasi, V.; Castelli, P.; Strosberg, J.; Zamboni, G.; Falconi, M.; Silvestris, F. | |
| Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors | 1-gen-2020 | Cives, Mauro; Pelle', Eleonora; Strosberg, Jonathan | |
| Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology | 1-gen-2018 | Palmirotta, Raffaele; Lovero, Domenica; Cafforio, Paola; Felici, Claudia; Mannavola, Francesco; Pellè, Eleonora; Quaresmini, Davide; Tucci, Marco Gaetano; Silvestris, Franco | |
| PIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo | 1-gen-2017 | Cafforio, Paola; Viggiano, Luigi; Mannavola, Francesco; Pellè, Eleonora; Caporusso, Concetta; Maiorano, Eugenio; Felici, Claudia; Silvestris, Francesco | |
| The management of refractory carcinoid syndrome: challenges and opportunities ahead | 1-gen-2018 | Cives, Mauro; Pelle', Eleonora; Silvestris, Franco | |
| The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. | 1-gen-2019 | Cives, M; Pelle', E; Quaresmini, D; Mandriani, Barbara; Tucci, M; Silvestris, F. |